In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials (PDQ®)

  • First Published: 9/1/2002
  • Last Modified: 2/29/2008

Page Options

  • Print This Page
  • Email This Document
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
LiveHelp online chat

Clinical Trials (PDQ®)

Study of Individuals and Families at High Risk for Melanoma

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Related Information
Registry Information

Alternate Title

Study of Clinical, Laboratory, and Epidemiologic Characteristics of Individuals and Families at High Risk for Melanoma

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
No phase specifiedEducational/Counseling/Training, Genetics, Natural history/EpidemiologyActiveAny ageNCINCI-02-C-0211
NCT00045240

Special Category: NIH Clinical Center trial, NCI Web site featured trial

Trial Description

Purpose:

Studying individuals and families at high risk for melanoma may help to identify other persons at risk and the genes involved in the development of melanoma.

Study to identify genetic and environmental factors related to melanoma risk in individuals and families at high risk for melanoma.

Eligibility:

Eligibility criteria include the following:

  • Any age
  • Risk factors such as family or personal history of melanoma or environmental or genetic factors known to increase the risk of melanoma
  • At least three living blood relatives with melanoma
  • For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Individuals and families will complete questionnaires, undergo a physical examination, and have blood samples drawn for testing. Some individuals may undergo magnetic resonance imaging (MRI) and/or skin biopsy. Each family member will receive educational materials and individual counseling about melanoma risk. Some individuals may also undergo genetic testing and genetic counseling. Individuals will be evaluated periodically.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

NCI - Center for Cancer Research

Margaret Tucker, MD, Protocol chair
Ph: 240-276-7396

Trial Sites

U.S.A.
Maryland
  Bethesda
 NCI - Division of Cancer Epidemiology and Genetics
 Genetic Epidemiology Branch Referral Nurse
Ph: 800-518-8474
 Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
 Clinical Trials Office - Warren Grant Magnusen Clinical Center - NCI Clinical Trials Referral Office
Ph: 888-NCI-1937

Related Information

Featured trial article

Registry Information
Official Title Clinical, Laboratory And Epidemiologic Characterization Of Individuals And Families At High Risk Of Melanoma
Trial Start Date 2002-06-03
Trial Completion Date 2012-12-31 (estimated)
Registered in ClinicalTrials.gov NCT00045240
Date Submitted to PDQ 2002-07-01
Information Last Verified 2007-02-08

Back to TopBack to Top